Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from ACR Appropriateness Criteria® external beam radiation therapy treatment planning for clinically localized prostate cancer, part I of II. Local targets link to admitted publications; unresolved targets remain external evidence.
Cancer statistics, 2015
2015 · External reference
Time trends and local variation in primary treatment of localized prostate cancer
10.1200/jco.2009.26.0133 · 2010 · External reference
Radical prostatectomy vs. intensity-modulated radiation therapy in the management of localized prostate adenocarcinoma
10.1016/j.radonc.2009.09.001 · 2009 · External reference
Outcomes for intermediate risk prostate cancer: Are there advantages for surgery, external radiation, or brachytherapy?
10.1016/j.urolonc.2008.04.001 · 2009 · External reference
Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy > or =72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer
10.1016/s0360-3016(03)00784-3 · 2004 · External reference
Prostate cancer, version 2.2014
10.6004/jnccn.2014.0072 · 2014 · External reference
ACR appropriateness Criteria(R) Postradical prostatectomy irradiation in prostate cancer
2014 · External reference
ACR Appropriateness Criteria(R) Definitive External-Beam Irradiation in stage T1 and T2 prostate cancer
10.1097/coc.0000000000000049 · 2014 · External reference
Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer
10.1001/jama.280.11.969 · 1998 · External reference
Systematic review of hypofractionated radiation therapy for prostate cancer
10.1016/j.ctrv.2013.01.008 · 2013 · External reference
Stereotactic body radiation therapy for prostate cancer: Is the technology ready to be the standard of care?
10.1016/j.ctrv.2012.10.003 · 2013 · External reference
Three-dimensional conformal therapy versus standard radiation therapy in localized carcinoma of prostate: An update
10.3816/cgc.2002.n.011 · 2002 · External reference
Long-term failure patterns and survival in a randomized dose-escalation trial for prostate cancer. Who dies of disease?
10.1016/j.ijrobp.2010.01.006 · 2011 · External reference
Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer
10.1016/j.ijrobp.2007.06.054 · 2008 · External reference
Clinical outcome of patients treated with 3D conformal radiation therapy (3D-CRT) for prostate cancer on RTOG 9406
10.1016/j.ijrobp.2011.12.070 · 2012 · External reference
Long-term toxicity following 3D conformal radiation therapy for prostate cancer from the RTOG 9406 phase I/II dose escalation study
10.1016/j.ijrobp.2009.01.062 · 2010 · External reference
Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer
10.1016/s0167-8140(99)00100-0 · 2000 · External reference
Randomized trial of hypofractionated external-beam radiotherapy for prostate cancer
10.1200/jco.2013.51.1972 · 2013 · External reference
Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer
10.1001/jama.2012.460 · 2012 · External reference
Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer
10.1016/j.ijrobp.2011.11.047 · 2012 · External reference
Stereotactic body radiotherapy as boost for organ-confined prostate cancer
10.1177/153303461000900605 · 2010 · External reference
Stereotactic body radiation therapy for low, intermediate, and high-risk prostate cancer: Disease control and quality of life
10.1016/j.ijrobp.2011.06.204 · 2011 · External reference
Quality of life and toxicity after SBRT for organ-confined prostate cancer, a 7-year study
10.3389/fonc.2014.00301 · 2014 · External reference
Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: Long-term results from Proton Radiation Oncology Group/American College of Radiology 95-09
10.1200/jco.2009.25.8475 · 2010 · External reference
70 Gy versus 80 Gy in localized prostate cancer: 5-year results of GETUG 06 randomized trial
10.1016/j.ijrobp.2010.03.049 · 2011 · External reference
Update of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer
10.1016/j.ijrobp.2008.02.073 · 2008 · External reference
Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: First results from the MRC RT01 randomised controlled trial
10.1016/s1470-2045(07)70143-2 · 2007 · External reference
Target volume definition in conformal radiotherapy for prostate cancer: Quality assurance in the MRC RT-01 trial
10.1016/s0167-8140(00)00191-2 · 2000 · External reference
10.1016/j.ijrobp.2014.10.035
10.1016/j.ijrobp.2014.10.035 · External reference
Unresolved reference
External reference
State of the art on dose prescription, reporting and recording in intensity-modulated radiation therapy (ICRU report No. 83)
10.1016/j.canrad.2011.04.003 · 2011 · External reference
Guidelines for primary radiotherapy of patients with prostate cancer
10.1016/j.radonc.2006.05.012 · 2006 · External reference
Unresolved reference
External reference
Influence of intrafraction motion on margins for prostate radiotherapy
10.1016/j.ijrobp.2005.12.033 · 2006 · External reference
Pelvic normal tissue contouring guidelines for radiation therapy: A Radiation Therapy Oncology Group consensus panel atlas
10.1016/j.ijrobp.2012.01.023 · 2012 · External reference
Radiographic and anatomic basis for prostate contouring errors and methods to improve prostate contouring accuracy
10.1016/j.ijrobp.2009.02.019 · 2010 · External reference
Interphysician variability in defining the planning target volume in the irradiation of prostate and seminal vesicles
10.1016/s0167-8140(98)00028-0 · 1998 · External reference
Target definition in prostate, head, and neck
10.1016/j.semradonc.2005.01.005 · 2005 · External reference
The contribution of magnetic resonance imaging to the three-dimensional treatment planning of localized prostate cancer
10.1016/s0360-3016(99)00288-6 · 1999 · External reference
Can images obtained with high field strength magnetic resonance imaging reduce contouring variability of the prostate?
10.1016/j.ijrobp.2010.03.019 · 2011 · External reference
Definition of the prostate in CT and MRI: A multi-observer study
10.1016/s0360-3016(98)00351-4 · 1999 · External reference
Prostate volume determination: Differential volume measurements comparing CT and TRUS
10.1016/j.radonc.2006.10.003 · 2006 · External reference
Prostate volume contouring: A 3D analysis of segmentation using 3DTRUS, CT, and MR
10.1016/j.ijrobp.2006.11.027 · 2007 · External reference
Functional anatomy of the prostate: Implications for treatment planning
10.1016/j.ijrobp.2005.02.036 · 2005 · External reference
Vessel-sparing prostate radiotherapy: Dose limitation to critical erectile vascular structures (internal pudendal artery and corpus cavernosum) defined by MRI
10.1016/j.ijrobp.2004.04.070 · 2005 · External reference
Reduction of dose delivered to the rectum and bulb of the penis using MRI delineation for radiotherapy of the prostate
10.1016/s0360-3016(03)01446-9 · 2003 · External reference
Interobserver delineation variation using CT versus combined CT + MRI in intensity-modulated radiotherapy for prostate cancer
10.1007/s00066-005-1383-x · 2005 · External reference
Magnetic resonance imaging in the radiation treatment planning of localized prostate cancer using intra-prostatic fiducial markers for computed tomography co-registration
10.1016/s0167-8140(02)00407-3 · 2003 · External reference
MRI-based treatment planning for radiotherapy: Dosimetric verification for prostate IMRT
10.1016/j.ijrobp.2004.05.068 · 2004 · External reference
Effects of geometric distortion in 0.2T MRI on radiotherapy treatment planning of prostate cancer
10.1016/j.radonc.2003.12.012 · 2004 · External reference
Radiotherapy treatment planning of prostate cancer using magnetic resonance imaging alone
10.1016/s0167-8140(02)00440-1 · 2003 · External reference
Advances in magnetic resonance imaging: How they are changing the management of prostate cancer
10.1016/j.eururo.2011.02.034 · 2011 · External reference
Role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer
10.1016/j.eururo.2007.12.034 · 2008 · External reference
Multiparametric MRI and prostate cancer diagnosis and risk stratification
10.1097/mou.0b013e32835481c2 · 2012 · External reference
Functional magnetic resonance imaging in prostate cancer
10.1016/j.eururo.2009.01.027 · 2009 · External reference
Clinicopathologic analysis of extracapsular extension in prostate cancer: Should the clinical target volume be expanded posterolaterally to account for microscopic extension?
10.1016/j.ijrobp.2006.02.039 · 2006 · External reference
Is seminal vesicle ablation mandatory for all patients undergoing radical prostatectomy? A multivariate analysis on 1283 patients
10.1016/j.eururo.2004.03.021 · 2004 · External reference
Prediction of radial distance of extraprostatic extension from pretherapy factors
10.1016/j.ijrobp.2007.03.016 · 2007 · External reference
An updated prostate cancer staging nomogram (Partin tables) based on cases from 2006 to 2011
10.1111/j.1464-410x.2012.11324.x · 2013 · External reference
Treatment of prostate cancer with radiotherapy: Should the entire seminal vesicles be included in the clinical target volume?
10.1016/s0360-3016(02)03011-0 · 2002 · External reference
Variation in the definition of clinical target volumes for pelvic nodal conformal radiation therapy for prostate cancer
10.1016/j.ijrobp.2008.08.003 · 2009 · External reference
RTOG GU Radiation oncology specialists reach consensus on pelvic lymph node volumes for high-risk prostate cancer
10.1016/j.ijrobp.2008.08.002 · 2009 · External reference
Post-prostatectomy radiation therapy: Consensus guidelines of the Australian and New Zealand Radiation Oncology Genito-Urinary Group
10.1016/j.radonc.2008.05.006 · 2008 · External reference
Guidelines for target volume definition in post-operative radiotherapy for prostate cancer, on behalf of the EORTC Radiation Oncology Group
10.1016/j.radonc.2007.07.017 · 2007 · External reference
Anatomic boundaries of the clinical target volume (prostate bed) after radical prostatectomy
10.1016/j.ijrobp.2007.04.068 · 2007 · External reference
Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer
10.1016/j.ijrobp.2009.02.006 · 2010 · External reference
Local recurrence map to guide target volume delineation after radical prostatectomy
10.1016/j.prro.2014.02.007 · 2014 · External reference
Effect of pelvic lymph node irradiation in salvage therapy for patients with prostate cancer with a biochemical relapse following radical prostatectomy
10.3816/cgc.2004.n.018 · 2004 · External reference
Radiotherapy after prostatectomy: Improved biochemical relapse-free survival with whole pelvic compared with prostate bed only for high-risk patients
10.1016/j.ijrobp.2007.02.035 · 2007 · External reference
Comparative toxicity and dosimetric profile of whole-pelvis versus prostate bed-only intensity-modulated radiation therapy after prostatectomy
10.1016/j.ijrobp.2011.04.041 · 2012 · External reference
Unresolved reference
External reference
Postoperative radiotherapy for prostate cancer: A comparison of four consensus guidelines and dosimetric evaluation of 3D-CRT versus tomotherapy IMRT
10.1016/j.ijrobp.2011.12.081 · 2012 · External reference
Delineation of the postprostatectomy prostate bed using computed tomography: Interobserver variability following the EORTC delineation guidelines
10.1016/j.ijrobp.2010.12.057 · 2011 · External reference
Magnetic resonance imaging in postprostatectomy radiotherapy planning
10.1016/j.ijrobp.2010.11.004 · 2012 · External reference
Postoperative radiotherapy in prostate cancer: The case of the missing target
10.1016/j.ijrobp.2011.09.039 · 2012 · External reference
Three-dimensional intrafractional movement of prostate measured during real-time tumor-tracking radiotherapy in supine and prone treatment positions
10.1016/s0360-3016(02)02882-1 · 2002 · External reference
The effect of patient position and treatment technique in conformal treatment of prostate cancer
10.1016/s0360-3016(99)00207-2 · 1999 · External reference
Cine-magnetic resonance imaging assessment of intrafraction motion for prostate cancer patients supine or prone with and without a rectal balloon
10.1097/coc.0b013e31819fdf7c · 2010 · External reference
A prospective study of intrafraction prostate motion in the prone vs. supine position
10.1016/j.ijrobp.2009.04.041 · 2010 · External reference
Dosimetric effects of the prone and supine positions on image guided localized prostate cancer radiotherapy
10.1016/j.radonc.2007.11.034 · 2008 · External reference
A comparison of ventilatory prostate movement in four treatment positions
10.1016/s0360-3016(00)00751-3 · 2000 · External reference
Respiratory-induced prostate motion: Quantification and characterization
10.1016/s0360-3016(00)00603-9 · 2000 · External reference
A randomized trial evaluating rigid immobilization for pelvic irradiation
10.1016/s0360-3016(03)00222-0 · 2003 · External reference
A randomized comparison of interfraction and intrafraction prostate motion with and without abdominal compression
10.1016/j.radonc.2008.01.019 · 2008 · External reference
A randomized trial of supine vs. prone positioning in patients undergoing escalated dose conformal radiotherapy for prostate cancer
10.1016/j.radonc.2003.08.007 · 2004 · External reference
An evaluation of intrafraction motion of the prostate in the prone and supine positions using electromagnetic tracking
10.1016/j.radonc.2011.02.012 · 2011 · External reference
Changes in the pelvic anatomy after an IMRT treatment fraction of prostate cancer
10.1016/j.ijrobp.2007.01.069 · 2007 · External reference
Adverse effect of a distended rectum in intensity-modulated radiotherapy (IMRT) treatment planning of prostate cancer
10.1016/j.radonc.2006.03.004 · 2006 · External reference
Increased risk of biochemical and local failure in patients with distended rectum on the planning CT for prostate cancer radiotherapy
10.1016/j.ijrobp.2004.11.032 · 2005 · External reference
Assessing the daily consistency of bladder filling using an ultrasonic Bladderscan device in men receiving radical conformal radiotherapy for prostate cancer
10.1259/bjr/50048151 · 2011 · External reference
Using cone-beam computed tomography to evaluate the impact of bladder filling status on target position in prostate radiotherapy
10.1007/s00066-009-1987-7 · 2009 · External reference
Effect of bladder filling on doses to prostate and organs at risk: Atreatment planning study
10.1120/jacmp.v8i1.2286 · 2007 · External reference
Increased risk of biochemical and clinical failure for prostate patients with a large rectum at radiotherapy planning: Results from the Dutch trial of 68 GY versus 78 Gy
10.1016/j.ijrobp.2006.11.014 · 2007 · External reference
The influence of a dietary protocol on cone beam CT-guided radiotherapy for prostate cancer patients
10.1016/j.ijrobp.2008.03.036 · 2008 · External reference
A cinematic magnetic resonance imaging study of milk of magnesia laxative and an antiflatulent diet to reduce intrafraction prostate motion
10.1016/j.ijrobp.2009.06.005 · 2010 · External reference
Clinical application of image-guided radiotherapy in bladder and prostate cancer
10.1016/j.clon.2010.06.020 · 2010 · External reference
Which bowel preparation is best? Comparison of a high-fibre diet leaflet, daily microenema and no preparation in prostate cancer patients treated with radical radiotherapy to assess the effect on planned target volume shifts due to rectal distension
10.1259/bjr.20130457 · 2013 · External reference
Motion and shape change when using an endorectal balloon during prostate radiation therapy
10.1016/j.radonc.2006.10.004 · 2006 · External reference
Is there a role for endorectal balloons in prostate radiotherapy? A systematic review
10.1016/j.radonc.2010.04.016 · 2010 · External reference
Anal wall sparing effect of an endorectal balloon in 3D conformal and intensity-modulated prostate radiotherapy
10.1016/j.radonc.2009.05.014 · 2009 · External reference
Reduced late rectal mucosal changes after prostate three-dimensional conformal radiotherapy with endorectal balloon as observed in repeated endoscopy
10.1016/j.ijrobp.2006.09.034 · 2007 · External reference
Evolution of advanced technologies in prostate cancer radiotherapy
10.1038/nrurol.2013.185 · 2013 · External reference
Tolerance of endorectal balloon in 396 patients treated with intensity-modulated radiation therapy (IMRT) for prostate cancer
10.1097/01.coc.0000195099.26957.63 · 2006 · External reference
The influence of a rectal balloon tube as internal immobilization device on variations of volumes and dose-volume histograms during treatment course of conformal radiotherapy for prostate cancer
10.1016/s0360-3016(01)01821-1 · 2002 · External reference
Rectal dose sparing with a balloon catheter and ultrasound localization in conformal radiation therapy for prostate cancer
10.1016/s0167-8140(03)00056-2 · 2003 · External reference
Stereotactic body radiation therapy for prostate cancer: Review of experience of a multicenter phase I/II dose-escalation study
10.3389/fonc.2014.00319 · 2014 · External reference
Phase I dose-escalation study of stereotactic body radiation therapy for low- and intermediate-risk prostate cancer
10.1200/jco.2010.31.4377 · 2011 · External reference
Effects of prostate-rectum separation on rectal dose from external beam radiotherapy
10.1016/j.ijrobp.2009.07.1679 · 2010 · External reference
Prostate hypofractionated radiation therapy: Injection of hyaluronic acid to better preserve the rectal wall
10.1016/j.ijrobp.2012.11.027 · 2013 · External reference
Prospective evaluation of a hydrogel spacer for rectal separation in dose-escalated intensity-modulated radiotherapy for clinically localized prostate cancer
10.1186/1471-2407-13-27 · 2013 · External reference
Application of a spacer gel to optimize three-dimensional conformal and intensity modulated radiotherapy for prostate cancer
10.1016/j.radonc.2011.09.005 · 2011 · External reference
A multi-institutional clinical trial of rectal dose reduction via injected polyethylene-glycol hydrogel during intensity modulated radiation therapy for prostate cancer: Analysis of dosimetric outcomes
10.1016/j.ijrobp.2012.12.019 · 2013 · External reference
Human collagen injections to reduce rectal dose during radiotherapy
10.1016/j.ijrobp.2011.02.034 · 2012 · External reference
Interstitial biodegradable balloon for reduced rectal dose during prostate radiotherapy: Results of a virtual planning investigation based on the pre- and post-implant imaging data of an international multicenter study
10.1016/j.radonc.2013.01.007 · 2013 · External reference
Application of an interstitial and biodegradable balloon system for prostate-rectum separation during prostate cancer radiotherapy: A prospective multi-center study
10.1186/1748-717x-8-96 · 2013 · External reference
Intensity modulated proton and photon therapy for early prostate cancer with or without transperineal injection of a polyethylen glycol spacer: A treatment planning comparison study
10.1016/j.ijrobp.2012.03.028 · 2012 · External reference
Dosimetric implications of an injection of hyaluronic acid for preserving the rectal wall in prostate stereotactic body radiation therapy
10.1016/j.ijrobp.2013.10.039 · 2014 · External reference
Prostate and seminal vesicle volume based consideration of prostate cancer patients for treatment with 3D-conformal or intensity-modulated radiation therapy
10.1118/1.3451125 · 2010 · External reference
Dosimetric outcomes in prostate brachytherapy: Is downsizing the prostate with androgen deprivation necessary?
10.1016/j.brachy.2008.11.009 · 2009 · External reference
Prostate volume reduction with androgen deprivation therapy before interstitial brachytherapy
10.1016/s0022-5347(05)65001-x · 2002 · External reference
Neoadjuvant androgen ablation prior to radiotherapy for prostate cancer: Reducing the potential morbidity of therapy
10.1016/s0090-4295(97)00168-4 · 1997 · External reference
Outcomes in men with large prostates (≥ 60 cm(3)) treated with definitive proton therapy for prostate cancer
10.3109/0284186x.2012.744467 · 2013 · External reference
Anatomic variation and dosimetric consequences of neoadjuvant hormone therapy before radiation therapy for prostate cancer
10.1016/j.prro.2012.10.004 · 2013 · External reference
Constrained-beam inverse planning for intensity-modulated radiation therapy of prostate cancer patients with bilateral hip prostheses
10.1111/j.1754-9485.2012.02456.x · 2012 · External reference
Metal artifact reduction software used with abdominopelvic dual-energy CT of patients with metal hip prostheses: Assessment of image quality and clinical feasibility
10.2214/ajr.13.10980 · 2014 · External reference
Clinical evaluation of a commercial orthopedic metal artifact reduction tool for CT simulations in radiation therapy
10.1118/1.4762814 · 2012 · External reference
A case study of radiotherapy planning for a bilateral metal hip prosthesis prostate cancer patient
10.1016/j.meddos.2005.06.001 · 2005 · External reference
Intensity modulated radiation therapy planning for patients with a metal hip prosthesis based on class solutions
10.1016/j.prro.2011.04.006 · 2012 · External reference
Automated generation of IMRT treatment plans for prostate cancer patients with metal hip prostheses: Comparison of different planning strategies
10.1118/1.4808117 · 2013 · External reference
Optimization of tomotherapy treatment planning for patients with bilateral hip prostheses
10.1186/1748-717x-9-43 · 2014 · External reference
Megavoltage CT images of helical tomotherapy unit for radiation treatment simulation: Impact on feasibility of treatment planning in a prostate cancer patient with bilateral femoral prostheses
10.1177/030089161109700215 · 2011 · External reference
The use of CT-MR image registration to define target volumes in pelvic radiotherapy in the presence of bilateral hip replacements
10.1259/bjr/28412864 · 2005 · External reference
Prostate delineation using CT and MRI for radiotherapy patients with bilateral hip prostheses
10.1016/j.radonc.2008.11.015 · 2009 · External reference
Stereotactic ultrasound for target volume definition in a patient with prostate cancer and bilateral total hip replacement
10.1016/j.prro.2014.08.008 · 2015 · External reference
Effect of metal hip prosthesis on the accuracy of electromagnetic localization tracking
10.1016/j.prro.2014.03.010 · 2015 · External reference
Dosimetric considerations for patients with HIP prostheses undergoing pelvic irradiation. Report of the AAPM Radiation Therapy Committee Task Group 63
10.1118/1.1565113 · 2003 · External reference
A dosimetric study of volumetric modulated arc therapy planning techniques for treatment of low-risk prostate cancer in patients with bilateral hip prostheses
10.4103/2278-330x.126506 · 2014 · External reference
Megavoltage CT in helical tomotherapy - clinical advantages and limitations of special physical characteristics
10.1177/153303460900800504 · 2009 · External reference
Anterior-oriented proton beams for prostate cancer: A multi-institutional experience
10.3109/0284186x.2014.986288 · 2015 · External reference
Dosimetric study of uniform scanning proton therapy planning for prostate cancer patients with a metal hip prosthesis, and comparison with volumetric-modulated arc therapy
10.1120/jacmp.v15i3.4611 · 2014 · External reference
Can megavoltage computed tomography reduce proton range uncertainties in treatment plans for patients with large metal implants?
10.1088/0031-9155/53/9/009 · 2008 · External reference
Daily electronic portal imaging for morbidly obese men undergoing radiotherapy for localized prostate cancer
10.1016/j.ijrobp.2003.12.027 · 2004 · External reference
Interfractional prostate shifts: Review of 1870 computed tomography (CT) scans obtained during image-guided radiotherapy using CT-on-rails for the treatment of prostate cancer
10.1016/j.ijrobp.2008.03.045 · 2008 · External reference
Implanted dosimeters identify radiation overdoses during IMRT for prostate cancer
10.1016/j.ijrobp.2011.12.094 · 2012 · External reference
Influence of obesity on biochemical and clinical failure after external-beam radiotherapy for localized prostate cancer
10.1002/cncr.22025 · 2006 · External reference
Impact of obesity on outcomes after definitive dose-escalated intensity-modulated radiotherapy for localized prostate cancer
10.1002/cncr.29472 · 2015 · External reference
Comparison of localization performance with implanted fiducial markers and cone-beam computed tomography for on-line image-guided radiotherapy of the prostate
10.1016/j.ijrobp.2006.10.039 · 2007 · External reference
Clinician's guide to prostate IMRT plan assessment and optimisation
10.1111/j.1754-9485.2010.02217.x · 2010 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Boosting imaging defined dominant prostatic tumors: A systematic review
10.1016/j.radonc.2013.04.027 · 2013 · External reference
Tolerance of normal tissue to therapeutic irradiation
10.1016/0360-3016(91)90171-y · 1991 · External reference
Guest editor's introduction to QUANTEC: A users guide
10.1016/j.ijrobp.2009.08.075 · 2010 · External reference
Radiation dose-volume effects in radiation-induced rectal injury
10.1016/j.ijrobp.2009.03.078 · 2010 · External reference
Late toxicity and quality of life after definitive treatment of prostate cancer: Redefining optimal rectal sparing constraints for intensity-modulated radiation therapy
10.1002/cam4.261 · 2014 · External reference
Preliminary toxicity analysis of 3-dimensional conformal radiation therapy versus intensity modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group 0126 prostate cancer trial
10.1016/j.ijrobp.2013.07.041 · 2013 · External reference
Radiation dose-volume effects of the urinary bladder
10.1016/j.ijrobp.2009.02.090 · 2010 · External reference
Radiation dose-volume effects and the penile bulb
10.1016/j.ijrobp.2009.04.094 · 2010 · External reference
Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Cleveland Clinic experience
10.1016/j.ijrobp.2007.01.067 · 2007 · External reference
Age and comorbid illness are associated with late rectal toxicity following dose-escalated radiation therapy for prostate cancer
10.1016/j.ijrobp.2012.10.042 · 2013 · External reference
Evaluating toxicity from definitive radiation therapy for prostate cancer in men with inflammatory bowel disease: Patient selection and dosimetric parameters with modern treatment techniques
10.1016/j.prro.2014.09.004 · 2015 · External reference
Low toxicity in inflammatory bowel disease patients treated with abdominal and pelvic radiation therapy
10.1097/coc.0000000000000010 · 2015 · External reference
On-line aSi portal imaging of implanted fiducial markers for the reduction of interfraction error during conformal radiotherapy of prostate carcinoma
10.1016/j.ijrobp.2004.03.038 · 2004 · External reference
Potentials of on-line repositioning based on implanted fiducial markers and electronic portal imaging in prostate cancer radiotherapy
10.1186/1748-717x-4-13 · 2009 · External reference
Examining margin reduction and its impact on dose distribution for prostate cancer patients undergoing daily cone-beam computed tomography
10.1016/j.ijrobp.2008.01.015 · 2008 · External reference
The management of imaging dose during image-guided radiotherapy: Report of the AAPM Task Group 75
10.1118/1.2775667 · 2007 · External reference
Reduction of dose delivered to organs at risk in prostate cancer patients via image-guided radiation therapy
10.1016/j.ijrobp.2009.06.068 · 2010 · External reference
Image-guided helical tomotherapy for localized prostate cancer: Technique and initial clinical observations
10.1120/jacmp.v8i3.2320 · 2007 · External reference
A comprehensive assessment by tumor site of patient setup using daily MVCT imaging from more than 3,800 helical tomotherapy treatments
10.1016/j.ijrobp.2008.11.054 · 2009 · External reference
The current status of image-guided external beam radiotherapy for prostate cancer
10.1097/mou.0b013e32833817aa · 2010 · External reference
Accuracy of a wireless localization system for radiotherapy
10.1016/j.ijrobp.2004.11.009 · 2005 · External reference
Observations on real-time prostate gland motion using electromagnetic tracking
10.1016/j.ijrobp.2007.11.054 · 2008 · External reference
Tradeoffs of integrating real-time tracking into IGRT for prostate cancer treatment
10.1088/0031-9155/54/17/n03 · 2009 · External reference
Implementation of an image guided intensity-modulated protocol for post-prostatectomy radiotherapy: Planning data and acute toxicity outcomes
10.1111/1754-9485.12043 · 2013 · External reference
Post-prostatectomy image-guided radiation therapy: Evaluation of toxicity and inter-fraction variation using online cone-beam CT
10.1111/j.1754-9485.2011.02305.x · 2011 · External reference
Prostate bed motion during intensity-modulated radiotherapy treatment
10.1016/j.ijrobp.2011.11.041 · 2012 · External reference
